Manufactured under strict WHO-GMP certified standards ensuring optimal therapeutic efficacy.
DIABETOLOGY
ADVEMPA M 12.5/500
Composition: Empagliflozin 12.5 mg + Metformin Hydrochloride 500 mg
Product specifications
Brand / DivisionAkaay Healthcare
Active compositionEmpagliflozin 12.5 mg + Metformin Hydrochloride 500 mg
Packaging size1 X 10 Tablets
Dosage formTablet
StrengthEmpagliflozin 12.5 mg + Metformin Hydrochloride 500 mg
Product overview
ADVEMPA M 12.5/500 contains Empagliflozin 12.5 mg and Metformin Hydrochloride 500 mg in a combination tablet formulation for the management of Type 2 diabetes mellitus.
Therapeutic indications
ADVEMPA M 12.5/500 is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.